P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

P359: IMPROVED OVERALL SURVIVAL AND MRD CLEARANCE WITH BLINATUMOMAB VS CHEMOTHERAPY AS PRE-TRANSPLANT CONSOLIDATION IN PEDIATRIC HIGH-RISK FIRST-RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

Bibliographic Details
Main Authors: F. Locatelli, G. Zugmaier, C. Rizzari, J. Morris, B. Gruhn, T. Klingebiel, R. Parasole, C. Linderkamp, C. Flotho, A. Petit, C. Micalizzi, Y. Zeng, R. Desai, W. Kormany, C. Eckert, A. Möricke, M. Sartor, O. Hrusak, C. Peters, V. Saha, L. Vinti, A. von Stackelberg
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000844324.04051.5b
Description
ISSN:2572-9241

Similar Items